- Home
- TM vs NVS Comparison
TM vs NVS Comparison
Compare TM & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TM | NVS |
|---|---|---|
| Founded | 1933 | 1895 |
| Country | Japan | Switzerland |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.4B | 266.5B |
| IPO Year | 1949 | 1991 |
Fundamental Metrics
Financial Performance| Metric | TM | NVS |
|---|---|---|
| Price | $216.78 | $139.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $118.00 |
| AVG Volume (30 Days) | 314.3K | ★ 1.6M |
| Earning Date | 02-04-2026 | 01-30-2026 |
| Dividend Yield | ★ 2.60% | 1.86% |
| EPS Growth | ★ 11.90 | N/A |
| EPS | ★ 23.96 | 7.30 |
| Revenue | ★ $333,707,283,016.00 | $56,372,000,000.00 |
| Revenue This Year | $5.57 | $9.38 |
| Revenue Next Year | $3.34 | $2.69 |
| P/E Ratio | ★ $8.99 | $18.59 |
| Revenue Growth | 6.44 | ★ 12.88 |
| 52 Week Low | $155.00 | $96.91 |
| 52 Week High | $220.56 | $140.18 |
Technical Indicators
Market Signals| Indicator | TM | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 71.10 |
| Support Level | $215.00 | $134.82 |
| Resistance Level | $220.56 | $140.18 |
| Average True Range (ATR) | 1.77 | 1.65 |
| MACD | 1.22 | 0.54 |
| Stochastic Oscillator | 85.86 | 87.98 |
Price Performance
Historical ComparisonAbout TM Toyota Motor Corporation
Founded in 1937, Toyota is one of the world's largest automakers, with 11.0 million units sold at retail in fiscal 2025, including 10.3 million across the Toyota and Lexus brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino; market share in Japan is about 50% excluding mini-vehicles, while US share is around 14%. The firm also owns stakes in Denso, a parts supplier, about 20% of Subaru, and holds investments in many other firms, including shares of Uber Technologies, Joby Aviation, Aurora Innovation, Isuzu Motors, and about 5% in each of Mazda and Suzuki. Fiscal 2025 sales excluding financial services were JPY 43.8 trillion. Toyota also has a financing arm and manufactures homes and boats.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.